Curatis Holding AG Sustainability Reports
Curatis Holding AG operates as a specialty pharmaceutical company focused on the acquisition, development, and distribution of medicines for rare and specialty care diseases. The company licenses and distributes specialty pharmaceuticals primarily in Switzerland while advancing its clinical drug pipeline.
Sector: Manufacturing
Country: Switzerland
Exchange: SIX Swiss Exchange
LEI: 506700VDL70GGMHR5758
FIGI: BBG001S7W7J0
6 reports from 2020 to 2025
